| myeloid cell differentiation | GO:0030099 | 233 | 0.664 | |
| biomineral tissue development | GO:0031214 | 64 | 0.162 | |
| ossification | GO:0001503 | 216 | 0.141 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.132 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.123 | |
| amine metabolic process | GO:0009308 | 45 | 0.123 | |
| defense response to other organism | GO:0098542 | 197 | 0.121 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.119 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.109 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.104 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.104 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.100 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.094 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.088 | |
| protein maturation | GO:0051604 | 176 | 0.088 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.083 | |
| protein processing | GO:0016485 | 163 | 0.082 | |
| forebrain development | GO:0030900 | 302 | 0.080 | |
| cartilage development | GO:0051216 | 140 | 0.078 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.077 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.076 | |
| neutrophil mediated killing of gram positive bacterium | GO:0070946 | 2 | 0.076 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.075 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.073 | |
| oxidation reduction process | GO:0055114 | 342 | 0.073 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.072 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.072 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.071 | |
| granzyme mediated apoptotic signaling pathway | GO:0008626 | 1 | 0.070 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.069 | |
| bone mineralization | GO:0030282 | 54 | 0.069 | |
| cytokine production | GO:0001816 | 319 | 0.066 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.065 | |
| defense response to bacterium | GO:0042742 | 119 | 0.065 | |
| fat cell differentiation | GO:0045444 | 160 | 0.064 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.063 | |
| immune effector process | GO:0002252 | 321 | 0.062 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.061 | |
| serotonin receptor signaling pathway | GO:0007210 | 8 | 0.058 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.058 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.057 | |
| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.056 | |
| negative regulation of growth | GO:0045926 | 99 | 0.056 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.056 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.055 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.055 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.055 | |
| response to drug | GO:0042493 | 75 | 0.052 | |
| neuronal action potential | GO:0019228 | 54 | 0.052 | |
| odontogenesis | GO:0042476 | 78 | 0.052 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.051 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.049 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.048 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.048 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.047 | |
| regulation of cell motility | GO:2000145 | 236 | 0.046 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.046 | |
| transmembrane transport | GO:0055085 | 412 | 0.046 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.045 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.044 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.043 | |
| innate immune response | GO:0045087 | 157 | 0.042 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.042 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.042 | |
| cell killing | GO:0001906 | 67 | 0.042 | |
| humoral immune response | GO:0006959 | 57 | 0.041 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.041 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.041 | |
| response to stilbenoid | GO:0035634 | 22 | 0.041 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.041 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.041 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.040 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.040 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.040 | |
| vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure | GO:0002025 | 3 | 0.039 | |
| response to nutrient levels | GO:0031667 | 109 | 0.039 | |
| positive regulation of immunological synapse formation | GO:2000522 | 1 | 0.039 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.038 | |
| bone development | GO:0060348 | 120 | 0.038 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.037 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.037 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.037 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.037 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.036 | |
| endocrine process | GO:0050886 | 39 | 0.036 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.036 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.036 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.035 | |
| glial cell differentiation | GO:0010001 | 131 | 0.035 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.035 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.034 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.034 | |
| camera type eye development | GO:0043010 | 266 | 0.033 | |
| digestive system development | GO:0055123 | 200 | 0.033 | |
| regulation of dendritic cell chemotaxis | GO:2000508 | 1 | 0.033 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.033 | |
| disruption of cells of other organism | GO:0044364 | 13 | 0.033 | |
| positive regulation of steroid hormone secretion | GO:2000833 | 2 | 0.033 | |
| regulation of defense response | GO:0031347 | 233 | 0.033 | |
| dibenzo p dioxin metabolic process | GO:0018894 | 1 | 0.033 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.033 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.032 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.032 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.031 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.031 | |
| regulation of secretion | GO:0051046 | 274 | 0.031 | |
| regulation of protein processing | GO:0070613 | 96 | 0.031 | |
| sensory perception | GO:0007600 | 245 | 0.031 | |
| organ growth | GO:0035265 | 117 | 0.031 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.031 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.031 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.030 | |
| cation transport | GO:0006812 | 399 | 0.030 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.029 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.029 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.029 | |
| histamine induced gastric acid secretion | GO:0001697 | 1 | 0.029 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.028 | |
| hormone metabolic process | GO:0042445 | 86 | 0.028 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.028 | |
| urogenital system development | GO:0001655 | 261 | 0.028 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.028 | |
| response to inorganic substance | GO:0010035 | 96 | 0.028 | |
| endocytosis | GO:0006897 | 168 | 0.028 | |
| negative regulation of adenylate cyclase activity | GO:0007194 | 1 | 0.028 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.027 | |
| single fertilization | GO:0007338 | 82 | 0.027 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.027 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.027 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.027 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.026 | |
| connective tissue development | GO:0061448 | 179 | 0.026 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.026 | |
| digestive tract development | GO:0048565 | 190 | 0.026 | |
| protein secretion | GO:0009306 | 111 | 0.026 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.026 | |
| fertilization | GO:0009566 | 127 | 0.025 | |
| g protein coupled receptor internalization | GO:0002031 | 3 | 0.025 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.025 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.025 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.025 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.025 | |
| activation of membrane attack complex | GO:0001905 | 4 | 0.025 | |
| action potential | GO:0001508 | 78 | 0.025 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.025 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.025 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.024 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.024 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.024 | |
| stem cell differentiation | GO:0048863 | 268 | 0.024 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.024 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.024 | |
| t helper 17 cell chemotaxis | GO:0035705 | 1 | 0.024 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.023 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.023 | |
| cell adhesion | GO:0007155 | 329 | 0.023 | |
| cellular response to temperature stimulus | GO:0071502 | 2 | 0.023 | |
| cellular response to starvation | GO:0009267 | 57 | 0.023 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.023 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.023 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.023 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.023 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.023 | |
| regulation of cell division | GO:0051302 | 76 | 0.022 | |
| hematopoietic stem cell migration | GO:0035701 | 1 | 0.022 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.022 | |
| regulation of ion transport | GO:0043269 | 215 | 0.022 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.022 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.022 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.022 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.022 | |
| regulation of systemic arterial blood pressure by circulatory renin angiotensin | GO:0001991 | 13 | 0.022 | |
| immune complex clearance | GO:0002434 | 2 | 0.021 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.021 | |
| skeletal system development | GO:0001501 | 356 | 0.021 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.021 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.021 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.021 | |
| positive regulation of heart rate by epinephrine norepinephrine | GO:0001996 | 4 | 0.021 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.021 | |
| response to amino acid | GO:0043200 | 37 | 0.020 | |
| spermatogenesis | GO:0007283 | 284 | 0.020 | |
| endothelial cell migration | GO:0043542 | 44 | 0.020 | |
| regulation of phospholipase c activity | GO:1900274 | 3 | 0.020 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.020 | |
| adaptive immune response | GO:0002250 | 155 | 0.020 | |
| phospholipase c activating serotonin receptor signaling pathway | GO:0007208 | 1 | 0.020 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.020 | |
| cell cell recognition | GO:0009988 | 44 | 0.020 | |
| regulation of microvillus organization | GO:0032530 | 3 | 0.020 | |
| positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation | GO:2000526 | 1 | 0.020 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.020 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.020 | |
| tissue migration | GO:0090130 | 68 | 0.020 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.019 | |
| angiogenesis | GO:0001525 | 201 | 0.019 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.019 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.019 | |
| bone morphogenesis | GO:0060349 | 78 | 0.019 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.019 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.019 | |
| leukocyte migration | GO:0050900 | 124 | 0.019 | |
| positive regulation of t cell costimulation | GO:2000525 | 2 | 0.019 | |
| neuromuscular process | GO:0050905 | 99 | 0.019 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.019 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.019 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.019 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.019 | |
| telencephalon development | GO:0021537 | 186 | 0.018 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.018 | |
| visual perception | GO:0007601 | 52 | 0.018 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.018 | |
| interleukin 12 secretion | GO:0072610 | 3 | 0.018 | |
| multicellular organism growth | GO:0035264 | 161 | 0.018 | |
| ear development | GO:0043583 | 200 | 0.018 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.018 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.018 | |
| cellular homeostasis | GO:0019725 | 240 | 0.018 | |
| pallium development | GO:0021543 | 120 | 0.018 | |
| gonad development | GO:0008406 | 141 | 0.018 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.018 | |
| gastrin induced gastric acid secretion | GO:0001698 | 1 | 0.017 | |
| regulation of cell migration | GO:0030334 | 219 | 0.017 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.017 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.017 | |
| t cell extravasation | GO:0072683 | 4 | 0.017 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.017 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.017 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.017 | |
| regulation of hematopoietic stem cell migration | GO:2000471 | 1 | 0.017 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.017 | |
| cation homeostasis | GO:0055080 | 212 | 0.017 | |
| sa node cell action potential | GO:0086015 | 4 | 0.016 | |
| response to starvation | GO:0042594 | 65 | 0.016 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.016 | |
| cell chemotaxis | GO:0060326 | 81 | 0.016 | |
| epithelium migration | GO:0090132 | 63 | 0.016 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.016 | |
| tissue homeostasis | GO:0001894 | 115 | 0.016 | |
| regulation of type 2 immune response | GO:0002828 | 18 | 0.016 | |
| regulation of tube size | GO:0035150 | 57 | 0.016 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.016 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.016 | |
| epithelial cell migration | GO:0010631 | 63 | 0.016 | |
| positive regulation of endothelial cell proliferation | GO:0001938 | 17 | 0.016 | |
| cellular response to lipid | GO:0071396 | 145 | 0.016 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.016 | |
| l amino acid transport | GO:0015807 | 32 | 0.016 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.016 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.016 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.016 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.016 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.016 | |
| negative regulation of t cell cytokine production | GO:0002725 | 1 | 0.016 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.016 | |
| cell recognition | GO:0008037 | 83 | 0.015 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.015 | |
| stem cell proliferation | GO:0072089 | 117 | 0.015 | |
| positive regulation of immune complex clearance by monocytes and macrophages | GO:0090265 | 2 | 0.015 | |
| gland development | GO:0048732 | 330 | 0.015 | |
| interleukin 13 secretion | GO:0072611 | 2 | 0.015 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.015 | |
| striated muscle cell development | GO:0055002 | 125 | 0.015 | |
| negative regulation of interleukin 5 production | GO:0032714 | 4 | 0.015 | |
| inflammatory response | GO:0006954 | 244 | 0.015 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.015 | |
| natural killer cell activation | GO:0030101 | 44 | 0.015 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.015 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.015 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.015 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.015 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.015 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.014 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.014 | |
| protein localization to organelle | GO:0033365 | 185 | 0.014 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.014 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.014 | |
| catecholamine uptake | GO:0090493 | 4 | 0.014 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.014 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.014 | |
| germ cell development | GO:0007281 | 185 | 0.014 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.014 | |
| plasma membrane organization | GO:0007009 | 90 | 0.014 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.014 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.014 | |
| cellular response to antibiotic | GO:0071236 | 4 | 0.014 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.014 | |
| t helper 2 cell cytokine production | GO:0035745 | 4 | 0.014 | |
| response to corticosterone | GO:0051412 | 1 | 0.014 | |
| activation of immune response | GO:0002253 | 138 | 0.014 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.014 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.014 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.014 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.014 | |
| extracellular structure organization | GO:0043062 | 148 | 0.014 | |
| wound healing | GO:0042060 | 157 | 0.014 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.014 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.014 | |
| negative regulation of interleukin 13 secretion | GO:2000666 | 1 | 0.013 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.013 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.013 | |
| stem cell development | GO:0048864 | 219 | 0.013 | |
| protein oligomerization | GO:0051259 | 67 | 0.013 | |
| epithelial cell development | GO:0002064 | 159 | 0.013 | |
| maintenance of location | GO:0051235 | 89 | 0.013 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.013 | |
| nucleosome positioning | GO:0016584 | 4 | 0.013 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.013 | |
| positive regulation of phospholipase c activity | GO:0010863 | 2 | 0.013 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.013 | |
| negative regulation of type 2 immune response | GO:0002829 | 8 | 0.013 | |
| response to acid chemical | GO:0001101 | 111 | 0.013 | |
| sperm ejaculation | GO:0042713 | 1 | 0.013 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.013 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.013 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.013 | |
| axon ensheathment | GO:0008366 | 76 | 0.013 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.013 | |
| regulation of catecholamine uptake involved in synaptic transmission | GO:0051940 | 2 | 0.013 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.013 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.013 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.013 | |
| palate development | GO:0060021 | 76 | 0.012 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.012 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.012 | |
| porphyrin containing compound metabolic process | GO:0006778 | 22 | 0.012 | |
| cellular response to ammonium ion | GO:0071242 | 2 | 0.012 | |
| appendage development | GO:0048736 | 166 | 0.012 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.012 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.012 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.012 | |
| negative regulation of cyclase activity | GO:0031280 | 1 | 0.012 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.012 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.012 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.012 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.012 | |
| chloride transmembrane transport | GO:1902476 | 24 | 0.012 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.012 | |
| myelination | GO:0042552 | 74 | 0.012 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.012 | |
| monoamine transport | GO:0015844 | 33 | 0.012 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.012 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.012 | |
| long chain fatty acid metabolic process | GO:0001676 | 26 | 0.012 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.012 | |
| endocrine system development | GO:0035270 | 98 | 0.012 | |
| synaptic transmission glycinergic | GO:0060012 | 2 | 0.012 | |
| regulation of endothelial cell proliferation | GO:0001936 | 23 | 0.012 | |
| response to steroid hormone | GO:0048545 | 56 | 0.012 | |
| proprioception | GO:0019230 | 4 | 0.012 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.012 | |
| tetrapyrrole metabolic process | GO:0033013 | 22 | 0.012 | |
| response to iron ion | GO:0010039 | 4 | 0.012 | |
| response to peptide hormone | GO:0043434 | 127 | 0.012 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.012 | |
| muscle tissue development | GO:0060537 | 308 | 0.012 | |
| negative regulation of cyclic nucleotide metabolic process | GO:0030800 | 5 | 0.012 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.012 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.012 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.012 | |
| negative regulation of leukocyte mediated immunity | GO:0002704 | 29 | 0.012 | |
| regulation of cell killing | GO:0031341 | 40 | 0.012 | |
| killing of cells in other organism involved in symbiotic interaction | GO:0051883 | 13 | 0.011 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.011 | |
| negative regulation of purine nucleotide metabolic process | GO:1900543 | 16 | 0.011 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.011 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.011 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.011 | |
| endomembrane system organization | GO:0010256 | 147 | 0.011 | |
| mapk cascade | GO:0000165 | 281 | 0.011 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.011 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.011 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.011 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.011 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.011 | |
| linoleic acid metabolic process | GO:0043651 | 6 | 0.011 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.011 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.011 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.011 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.011 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.011 | |
| exogenous drug catabolic process | GO:0042738 | 1 | 0.011 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.011 | |
| neutrophil mediated immunity | GO:0002446 | 19 | 0.011 | |
| positive regulation of monocyte extravasation | GO:2000439 | 1 | 0.011 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.011 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.011 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.011 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.011 | |
| sensitization | GO:0046960 | 2 | 0.011 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.011 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.011 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.011 | |
| positive regulation of gliogenesis | GO:0014015 | 27 | 0.011 | |
| response to growth factor | GO:0070848 | 198 | 0.010 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.010 | |
| regulation of system process | GO:0044057 | 200 | 0.010 | |
| response to histamine | GO:0034776 | 1 | 0.010 | |
| regulation of protein transport | GO:0051223 | 163 | 0.010 | |
| eosinophil activation | GO:0043307 | 1 | 0.010 | |
| respiratory system development | GO:0060541 | 190 | 0.010 | |
| regulation of ossification | GO:0030278 | 112 | 0.010 | |
| exocytosis | GO:0006887 | 121 | 0.010 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.010 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.010 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.010 | |
| negative regulation of lyase activity | GO:0051350 | 1 | 0.010 | |
| regulation of receptor activity | GO:0010469 | 41 | 0.010 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.010 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.010 | |
| interaction with symbiont | GO:0051702 | 14 | 0.010 | |
| response to mineralocorticoid | GO:0051385 | 1 | 0.010 | |
| glucose homeostasis | GO:0042593 | 128 | 0.010 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.010 | |
| myotube differentiation | GO:0014902 | 105 | 0.010 | |
| negative regulation of leukocyte apoptotic process | GO:2000107 | 31 | 0.010 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.010 | |
